Home Product Cefepime and Tazobactam for Injection

Cefepime and Tazobactam for Injection

This formulation consists of:

Active Ingredients:
- Cefepime
- Tazobactam
Pharmacological Grade Solvents and Excipients

Benefits:

Broad-spectrum antibiotic effective against a wide range of both Gram-positive and Gram-negative bacteria
Treats serious infections caused by multidrug-resistant organisms
Suitable for the treatment of nosocomial (hospital-acquired) infections
Combats a variety of infections, including pneumonia, urinary tract infections, and intra-abdominal infections
Reduces the risk of bacterial resistance when used in combination with tazobactam

Available Variations in formulations:

We offer Cefepime and Tazobactam for Injection in the following strengths:

281.25 mg
562.5 mg
1125 mg
2.25 gm

Description
Additional information

Get In Touch

Product Details

Cefepime and Tazobactam for Injection combines the broad-spectrum antimicrobial activity of cefepime, a cephalosporin, with tazobactam, a beta-lactamase inhibitor. This combination makes it highly effective against a wide range of bacterial pathogens, including those resistant to other antibiotics. Cefepime works by disrupting the bacterial cell wall synthesis, while tazobactam inhibits beta-lactamase enzymes that some bacteria produce to resist cephalosporins. This combination is particularly useful in treating infections caused by multidrug-resistant organisms.

Indications

Complicated Urinary Tract Infections (cUTIs)
Pneumonia, including hospital-acquired and ventilator-associated
Intra-abdominal infections, such as peritonitis and abscesses
Complicated skin and soft tissue infections (cSSTIs)
Treatment of bacteremia caused by susceptible pathogens, including multidrug-resistant strains
Used to treat infections in immunocompromised patients, particularly those with neutropenia
Effective in managing septic patients, especially those with known or suspected multidrug-resistant infections

Dosage

Adults: Dosage and treatment duration are determined based on the infection site and severity.
Pediatric Patients: The appropriate dose of cefepime plus tazobactam should be determined by a healthcare provider based on the child’s weight and the type of infection.

Uses

N/A

Side Effects

N/A

Packaging Volume

Vial Pack + WFI

Minimum Order Quantity

15,000 Units

Delivery Time

45–60 Business Days

Top Categories

Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.